Rachel Jao is Head of Product, Market Access at Genesis Research Group, where she leads the development of products and solutions designed to support market access decision-making. She brings extensive experience across market access, product strategy, pricing analytics, data and analytics, and commercial strategy. Prior to Genesis, Rachel held leadership positions at Global Pricing Innovations and Decision Resources Group, where she led product innovation and analytics initiatives. Her published work includes research on value-based pricing, Medicare drug-price negotiation, real-world evidence in HTA, and clinical development for market access. Rachel holds an MPH from Columbia University and a BS in Biology from the University of California, San Diego.
